1:15:03 PM | 25/8/2005
The predecessor of the Hau Giang Pharmaceutical Joint stock Company was the Hau Giang Pharmaceutical Union Factory, which was set up on September 2, 1974. The factory’s function was to manufacture some simple medicines and receive medicines from the north for officers and soldiers, and people in the south during the anti-US resistance war.
Developing in hard times
After the south was liberated, with its outdated equipment and machinery, the company produced some pharmaceutical products. It mainly distributed products of centrally-run pharmaceutical factories and factories in Ho Chi Minh City to local people. When Vietnam began its renovation process in 1986, the company faced many difficulties and sometimes was on the edge of going bankrupt. In such a difficult context, the Hau Giang Pharmaceutical Company made great efforts. As a result, since 1992 the company has gained good business results with a high growth rate. The company’s products have been voted as Vietnamese high quality goods for nine years running. In recognition of the company’s achievements, in 1996 the company was presented with a Labour Hero title in the renovation process by the Party and the State.
Pham Thi Viet Nga, general director of the Hau Giang Pharmaceutical Joint stock Company, said that staff members with determination to overcome difficulties, and a passion for improving their skills, perceiving knowledge of the regional and word pharmaceutical industries were the key to the company’s success. Furthermore, the company has concentrated on developing its human resources by sending staff members to training courses organised in Vietnam and foreign countries.
The company’s effectiveness has improved since it was equitised in September 2004. Its production revenues and sales increased from VND 314.2 billion and VND 383.8 billion, respectively, in 2003 to VND 421 billion and VND 450.7 billion in 2004. The figures were put at VND 200 billion and VND 208.2 billion, respectively in the first five months of 2005. The company’s per capita income has reached VND 3.8 million per month.
Reaching world markets
To prepare for the international integration process, over the past few years the company has concentrated on building workshops, upgrading technology and equipment and applying quality management systems. The company is one of a handful enterprises having met ASEAN GMP (good manufacturing practice), GSP (good storage practice) and GLP (good laboratory practice). Also, the company has been granted the ISO 9001-2000 quality management system and its laboratory has met the ISO/IEC 17025 standard. Furthermore, the company has taken advantage of consulting services from foreign experts in Europe and the US. The company has initially succeeded with its hi-tech products, including Haginat 125mg biotic powder with active cefuroxim and Klamentin 125mg powder with active Amoxcyllin and Acid Clavulanic for children. The two products are effective in treatment and can replace imported products of the same kind. So far, the company’s products are used by 98 per cent of clinics, hospitals and medical centres in provinces and cities nationwide, including centrally-run hospitals in Ho Chi Minh City and Hanoi.
In 2005, the company has set a target of expanding its markets. Accordingly, apart from the traditional markets of Laos, Cambodia, Ukraine and Moldova, the company will focus on reaching new markets such as Singapore, Malaysia, France and Italy.
Hoang Lam
Vietnamese
